Skip to main content
. 2021 Mar 16;96(11):e1512–e1526. doi: 10.1212/WNL.0000000000011598

Figure 4. Randomized Treatment Effects on the Ordinal Modified Rankin Scale (mRS) Score by Lacunar and Nonlacunar Stroke.

Figure 4

*Adjusted for key prognostic covariates (age, sex, ethnicity, baseline NIH Stroke Scale [NIHSS] score, time from stroke onset to randomization, premorbid function [mRS scores 0 or 1], prior use of antithrombotic agents [aspirin, other antiplatelet agent, or warfarin], history of diabetes or cardiovascular disease [stroke, atrial fibrillation, coronary artery disease, valvular or other heart disease], assigned to intensive blood pressure–lowering group).